adropin



adropin

C1CC1H2HH2S3SS3R4RR4S5SS5A6AA6D7DD7V8VV8D9DD9S10SS10L11LL11S12SS12E13EE13S14SS14S15SS15P16PP16N17NN17S18SS18S19SS19P20PP20G21GG21P22PP22C23CC23P24PP24E25EE25K26KK26A27AA27P28PP28P29PP29P30PP30Q31QQ31K32KK32P33PP33S34SS34H35HH35E36EE36G37GG37S38SS38Y39YY39L40LL40L41LL41Q42QQ42P43PP43

SMILES None
InChIKey None
Sequence CHSRSADVDSLSESSPNSSPGPCPEKAPPPQKPSHEGSYLLQP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

adropin

C1CC1H2HH2S3SS3R4RR4S5SS5A6AA6D7DD7V8VV8D9DD9S10SS10L11LL11S12SS12E13EE13S14SS14S15SS15P16PP16N17NN17S18SS18S19SS19P20PP20G21GG21P22PP22C23CC23P24PP24E25EE25K26KK26A27AA27P28PP28P29PP29P30PP30Q31QQ31K32KK32P33PP33S34SS34H35HH35E36EE36G37GG37S38SS38Y39YY39L40LL40L41LL41Q42QQ42P43PP43

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.